| 1 |
[GO] |
2024―Jul―29 |
Firms’ digitalization during the COVID-19 pandemic: a tale of two stories |
Edgar Avalos, Xavier Cirera, Marcio Cruz, Leonardo Iacovone, Denis Medvedev, Gaurav Nayyar, Santiago Reyes Ortega |
| 2 |
[GO] |
2024―Jul―29 |
Innovation policy responses to address vulnerabilities of national innovation systems: long-lasting impacts of COVID-19 |
Sira Maliphol, Anwar Aridi, Jeong-Dong Lee, Thomas Woodson |
| 3 |
[GO] |
2024―Jul―29 |
Exploring the interplay between social distancing, innovation adoption, and privacy concerns amid the COVID-19 crisis |
Keungoui Kim, Sira Maliphol, Dongnyok Shim, Changjun Lee |
| 4 |
[GO] |
2024―Jul―29 |
SME digital transformation and the COVID-19 pandemic: a case study of a hard-hit metropolitan area |
Adelheid Holl, Ruth Rama |
| 5 |
[GO] |
2024―Jun―03 |
Institutional implications for science and industrial capacity: policy lessons from the UK’s pandemic response |
Andrew Watkins, Smita Srinivas, David Wield |
| 6 |
[GO] |
2023―Okt―27 |
Public perception of scientific advisory bodies: the case of France’s Covid-19 Scientific Council |
Émilien Schultz, Jeremy K Ward, Laëtitia Atlani-Duault |
| 7 |
[GO] |
2023―Jun―14 |
Responding to uncertainty in the COVID-19 pandemic: perspectives from Bavaria, Germany |
Amelia Fiske, Johannes Lange, Alena Buyx, Stuart McLennan |
| 8 |
[GO] |
2023―Mai―24 |
Herding in policy responses to coronavirus disease 2019 |
Jianfeng Guo, Xuemei Zhang, Fu Gu, Jiannan Zhu, Chao Deng, Xinze Zhao, Xiaohan Yang |
| 9 |
[GO] |
2023―Mai―13 |
Analysis of COVID-19 recovery and resilience policy in Finland: a transformative policy mix approach |
Paula Kivimaa, Jani Lukkarinen, David Lazarevic |
| 10 |
[GO] |
2022―Jan―13 |
Evolution of the emergency drug innovation network and policy implications: Evidence from COVID-19 drug patents |
Qing Xia, Lanjian Liu, Xiaoping Li |
